(Corrects third to last paragraph to say "the erosion from LOEs (loss of exclusivity)", not "from LOEs (levels of evidence)") ...

The company, co-founded by Cleveland Clinic in 2013, had a couple major objectives for the funding: expanding the commercial ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

It’s not too late, however, for Harvard to change its course, especially during the current community benefits negotiation ...

Rockville’s MaxCyte has made its first acquisition in its more than quarter-century of operation. It’s keeping its eyes out ...